GLA
GLA (galactosidase alpha, also known as GALA) encodes alpha-galactosidase A, a lysosomal glycoside hydrolase that removes terminal alpha-galactosyl groups from glycolipids and glycoproteins. It takes part in the lysosomal degradation of glycosphingolipids. Browse Assay Genie's current range of GLA research reagents below, or read on for the biology behind the target.
GLA catalyses the hydrolysis of glycosphingolipids and participates in their degradation in the lysosome. The enzyme cleaves terminal alpha-galactosyl moieties from glycolipids and glycoproteins. Its main substrate is ceramide trihexoside, and it can also hydrolyse melibiose into galactose and glucose.
The GLA gene encodes a homodimeric glycoprotein, alpha-galactosidase A (EC 3.2.1.22). It belongs to the glycosyl hydrolase 27 family and is placed by HGNC in the galactosidases alpha gene group. The gene is located on the X chromosome, and a mouse ortholog, Gla, is recorded. Researchers studying the GLA protein often look at how the enzyme is synthesised, processed and kept stable, since these steps determine its activity in the lysosome.
A variety of mutations in GLA affect the synthesis, processing and stability of the enzyme. These changes cause Fabry disease, a rare lysosomal storage disorder in which alpha-D-galactosyl glycolipid moieties cannot be catabolised. This link makes GLA a reference target for work on lysosomal biology, glycosphingolipid turnover and the biochemistry of storage disorders.
Mutations in GLA cause Fabry disease, so the enzyme is central to studies of this rare lysosomal storage disorder.
GLA is a model for how failure to degrade a lipid substrate in the lysosome leads to disease.
The enzyme hydrolyses ceramide trihexoside and takes part in glycosphingolipid degradation, making it relevant to lipid catabolism studies.
Disease-linked variants alter synthesis, processing and stability of the enzyme, informing work on glycoprotein folding and trafficking.
GLA encodes alpha-galactosidase A, a lysosomal enzyme that hydrolyses terminal alpha-galactosyl moieties from glycolipids and glycoproteins. It participates in glycosphingolipid degradation, predominantly acting on ceramide trihexoside, and it can also hydrolyse melibiose into galactose and glucose.
The HGNC approved name is galactosidase alpha, and the symbol GLA. GALA is a listed alias. The protein product is called alpha-galactosidase A in UniProt, and it carries the enzyme classification EC 3.2.1.22. It sits in the galactosidases alpha gene group.
Yes. Mutations in GLA that affect enzyme synthesis, processing and stability cause Fabry disease, a rare lysosomal storage disorder. A mouse ortholog, Gla, exists; check the datasheet of any product for its validated reactivity.
Other lysosomal hydrolases and glycosidases involved in glycosphingolipid and glycoconjugate catabolism.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P06280; product specifications from Assay Genie datasheets.